221 related articles for article (PubMed ID: 22857597)
1. Serum microRNAs as biomarkers for recurrence in melanoma.
Friedman EB; Shang S; de Miera EV; Fog JU; Teilum MW; Ma MW; Berman RS; Shapiro RL; Pavlick AC; Hernando E; Baker A; Shao Y; Osman I
J Transl Med; 2012 Aug; 10():155. PubMed ID: 22857597
[TBL] [Abstract][Full Text] [Related]
2. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Fleming NH; Zhong J; da Silva IP; Vega-Saenz de Miera E; Brady B; Han SW; Hanniford D; Wang J; Shapiro RL; Hernando E; Osman I
Cancer; 2015 Jan; 121(1):51-9. PubMed ID: 25155861
[TBL] [Abstract][Full Text] [Related]
3. Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF; Belitskaya-Lévy I; Rose AE; Zakrzewski J; Gaziel A; Hanniford D; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Osman I; Hernando E
Clin Cancer Res; 2010 Mar; 16(5):1577-86. PubMed ID: 20179230
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
[TBL] [Abstract][Full Text] [Related]
5. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
6. microRNA-10b is a prognostic biomarker for melanoma.
Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
9. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.
Tian R; Liu T; Qiao L; Gao M; Li J
Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.
Le HB; Zhu WY; Chen DD; He JY; Huang YY; Liu XG; Zhang YK
Med Oncol; 2012 Dec; 29(5):3190-7. PubMed ID: 22782668
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
[TBL] [Abstract][Full Text] [Related]
16. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
[TBL] [Abstract][Full Text] [Related]
17. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
Van Laar R; Lincoln M; Van Laar B
Br J Cancer; 2018 Mar; 118(6):857-866. PubMed ID: 29360813
[TBL] [Abstract][Full Text] [Related]
19. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Lv Y; Duanmu J; Fu X; Li T; Jiang Q
PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
[TBL] [Abstract][Full Text] [Related]
20. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
